Association between GPX1 and SOD2 genetic polymorphisms and overall survival in patients with metastatic urothelial bladder cancer: a single-center study in Serbia.

Nikic, Predrag; Dragicevic, Degan; Savic-Radojevic, Ana; Pljesa-Ercegovac, Marija; Coric, Vesna; Jovanovic, Djurdja; Bumbasirevic, Uros; Pekmezovic, Tatjana; Simic, Tatjana; Dzamic, Zoran; Matic, Marija

Nikic, Predrag; Dragicevic, Degan; Savic-Radojevic, Ana; Pljesa-Ercegovac, Marija; Coric, Vesna; Jovanovic, Djurdja; Bumbasirevic, Uros; Pekmezovic, Tatjana; Simic, Tatjana; Dzamic, Zoran; Matic, Marija.

Affiliation

Nikic P; Clinic of Urology, Clinical Center of Serbia, Belgrade, Serbia

J BUON ; 23(4): 1130-1135, 2018.

Article in En | MEDLINE | ID: mdl-30358222

Subject(s)

Glutathione Peroxidase/genetics; Superoxide Dismutase/genetics; Urinary Bladder Neoplasms/genetics; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Case-Control Studies; Cisplatin/administration & dosage; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Polymorphism, Single Nucleotide; Prospective Studies; Serbia/epidemiology; Survival Analysis; Urinary Bladder Neoplasms/drug therapy; Urinary Bladder Neoplasms/enzymology; Urinary Bladder Neoplasms/mortality; Glutathione Peroxidase GPX1

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Superoxide Dismutase / Urinary Bladder Neoplasms / Glutathione Peroxidase Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2018 Type: Article

Search on Google

XML

PubMed Links